Stallcup W B, Patrick J
Proc Natl Acad Sci U S A. 1980 Jan;77(1):634-8. doi: 10.1073/pnas.77.1.634.
Substance P inhibits carbamylcholine-induced 22Na+ uptake in the clonal cell line PC12. This inhibition is noncompetitive with agonist but competitive with Na+. Octahydrohistrionicotoxin (H8-HTX) also exhibits this same pattern of inhibition. Moreover, both substance P and H8-HTX are very effective in enhancing agonist-induced receptor desensitization. Local anesthetics, such as QX222, also cause inhibition that is competitive with Na+, but they have only marginal effects on desensitization. Because substance P and H8-HTX cannot by themselves cause desensitization, their action is dependent on and synergistic with the action of agonist. Furthermore, substance P and H8-HTX do not appear to compete for the same site as QX222, which is thought to bind to the ion channel. Finally, substance P can stabilize the desensitized state of the receptor even when added subsequent to the actual desensitization and removal of agonist. Thus, substance P does not require open ion channels for binding and may modulate the activity of the receptor-ionophore complex by binding to a distinct regulatory site.
P物质抑制克隆细胞系PC12中氨甲酰胆碱诱导的22Na+摄取。这种抑制作用对激动剂是非竞争性的,但对Na+是竞争性的。八氢组胺毒素(H8-HTX)也表现出相同的抑制模式。此外,P物质和H8-HTX在增强激动剂诱导的受体脱敏方面都非常有效。局部麻醉药,如QX222,也会引起与Na+竞争性的抑制作用,但它们对脱敏作用只有轻微影响。由于P物质和H8-HTX自身不能引起脱敏,它们的作用依赖于激动剂的作用并与之协同。此外,P物质和H8-HTX似乎并不与QX222竞争同一位点,QX222被认为与离子通道结合。最后,即使在实际脱敏和去除激动剂之后添加,P物质也能稳定受体的脱敏状态。因此,P物质结合不需要开放的离子通道,并且可能通过结合到一个独特的调节位点来调节受体-离子载体复合物的活性。